Rufutalkib
Rufutalkib is an orally active ALK modulator. It possesses thermodynamic and chemical stability, and can be used in research related to anaplastic large cell lymphoma, non-Hodgkin's lymphoma, inflammatory myofibroblastic tumor, neuroblastoma, glioblastoma, and ALK-positive malignancies.
For research use only. We do not sell to patients.
- CAS No.: 1609170-61-7
- Formula: C29H36ClN5O3S
- Molecular Weight:570.15
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Rufutalkib succinate Form VI is hygroscopic with a 5.4% weight gain at 80% RH, and converts to an amorphous state after moisture sorption testing[1].
Rufutalkib succinate Form VI has high solubility in simulated gastric fluid (7.34-7.35 mg/mL) and low solubility in fasted-state simulated intestinal fluid (0.10 mg/mL) over a 4-hour period at 37°C[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. .
Parmacokinetics
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1609170-61-7
-
Molecular Weight 570.15
-
Formula C29H36ClN5O3S
-
SMILES
CC1=CC(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(C(C)C)(=O)=O)=N2)=C4C(C[C@H](O4)C)=C1C5CCN(CC5)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)